135 related articles for article (PubMed ID: 9172011)
21. A novel recombinant vaccine which protects mice against ricin intoxication.
Smallshaw JE; Firan A; Fulmer JR; Ruback SL; Ghetie V; Vitetta ES
Vaccine; 2002 Sep; 20(27-28):3422-7. PubMed ID: 12213413
[TBL] [Abstract][Full Text] [Related]
22. Expression of active, processed ricin in transgenic tobacco.
Sehnke PC; Pedrosa L; Paul AL; Frankel AE; Ferl RJ
J Biol Chem; 1994 Sep; 269(36):22473-6. PubMed ID: 8077191
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of green fluorescent protein-ricin and monitoring of its intracellular trafficking.
Tagge E; Harris B; Burbage C; Hall P; Vesely J; Willingham M; Frankel A
Bioconjug Chem; 1997; 8(5):743-50. PubMed ID: 9327140
[TBL] [Abstract][Full Text] [Related]
24. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the Ricinus lectin B-chains. Galactose-binding ability of the 2 gamma subdomain of Ricinus communis agglutinin B-chain.
Sphyris N; Lord JM; Wales R; Roberts LM
J Biol Chem; 1995 Sep; 270(35):20292-7. PubMed ID: 7657599
[TBL] [Abstract][Full Text] [Related]
26. Mutational and structural analysis of the lectin activity in binding domain 2 of ricin B chain.
Lehar SM; Pedersen JT; Kamath RS; Swimmer C; Goldmacher VS; Lambert JM; Blättler WA; Guild BC
Protein Eng; 1994 Oct; 7(10):1261-6. PubMed ID: 7855142
[TBL] [Abstract][Full Text] [Related]
27. Cell surface and intracellular functions for ricin galactose binding.
Newton DL; Wales R; Richardson PT; Walbridge S; Saxena SK; Ackerman EJ; Roberts LM; Lord JM; Youle RJ
J Biol Chem; 1992 Jun; 267(17):11917-22. PubMed ID: 1601861
[TBL] [Abstract][Full Text] [Related]
28. Phage display of ricin B chain and its single binding domains: system for screening galactose-binding mutants.
Swimmer C; Lehar SM; McCafferty J; Chiswell DJ; Blättler WA; Guild BC
Proc Natl Acad Sci U S A; 1992 May; 89(9):3756-60. PubMed ID: 1373889
[TBL] [Abstract][Full Text] [Related]
29. An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
Lambert JM; Goldmacher VS; Collinson AR; Nadler LM; Blättler WA
Cancer Res; 1991 Dec; 51(23 Pt 1):6236-42. PubMed ID: 1718599
[TBL] [Abstract][Full Text] [Related]
30. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain.
Bilge A; Howell-Clark J; Ramakrishnan S; Press OW
Ther Immunol; 1994 Aug; 1(4):197-204. PubMed ID: 7584495
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of KDEL-terminated ricin toxins correlates with distribution of the KDEL receptor in the Golgi.
Tagge E; Chandler J; Tang BL; Hong W; Willingham MC; Frankel A
J Histochem Cytochem; 1996 Feb; 44(2):159-65. PubMed ID: 8609372
[TBL] [Abstract][Full Text] [Related]
32. Taming ricin toxin.
Kreitman RJ
Nat Biotechnol; 2003 Apr; 21(4):372-4. PubMed ID: 12665820
[No Abstract] [Full Text] [Related]
33. Monoclonal antibody-ricin A chain conjugates (immunotoxins): potential therapeutic agents for human colon carcinoma.
Gallagher WJ; Burk MW
J Surg Res; 1986 Feb; 40(2):159-66. PubMed ID: 3945071
[TBL] [Abstract][Full Text] [Related]
34. A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation.
Sokołowska I; Wälchli S; Węgrzyn G; Sandvig K; Słomińska-Wojewódzka M
Biochem J; 2011 Jun; 436(2):371-85. PubMed ID: 21388347
[TBL] [Abstract][Full Text] [Related]
35. Reduction of ricin toxicity without impairing the saccharide-binding properties by chemical modification of the carboxyl groups.
Solís D; Vallejo M; Díaz-Mauriño T
Anal Biochem; 1993 Feb; 209(1):117-22. PubMed ID: 8465943
[TBL] [Abstract][Full Text] [Related]
36. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.
Roy CJ; Brey RN; Mantis NJ; Mapes K; Pop IV; Pop LM; Ruback S; Killeen SZ; Doyle-Meyers L; Vinet-Oliphant HS; Didier PJ; Vitetta ES
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3782-7. PubMed ID: 25775591
[TBL] [Abstract][Full Text] [Related]
37. Role of the mannose receptor (CD206) in innate immunity to ricin toxin.
Gage E; Hernandez MO; O'Hara JM; McCarthy EA; Mantis NJ
Toxins (Basel); 2011 Sep; 3(9):1131-45. PubMed ID: 22069759
[TBL] [Abstract][Full Text] [Related]
38. IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cells.
Frankel A; Tagge E; Chandler J; Burbage C; Hancock G; Vesely J; Willingham M
Bioconjug Chem; 1995; 6(6):666-72. PubMed ID: 8608178
[TBL] [Abstract][Full Text] [Related]
39. Lectinochemical studies on the binding properties of a toxic lectin (ricin) isolated from the seeds of Ricinus communis.
Wu AM; Wu JH; Singh T; Hwang PY; Tsai MS; Herp A
Chang Gung Med J; 2005 Aug; 28(8):530-42. PubMed ID: 16265843
[TBL] [Abstract][Full Text] [Related]
40. Co-application of ricin A chain and a recombinant adenovirus expressing ricin B chain as a novel approach for cancer therapy.
Wang HB; Xia F; Ge J; Yin J; Tan LS; Zhang PD; Zhong J
Acta Pharmacol Sin; 2007 May; 28(5):657-62. PubMed ID: 17439722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
